DOGOFEN

This brand name is authorized in Nigeria.

Active ingredients

The drug DOGOFEN contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6346	Tablet	DOGOFEN TABLETS TAB 50 mg 1 X 10	96 RNW-PP-194960 DOGOFEN TABLETS DICLOFENAC SODIUM EACH UNCOATED TABLET CONTAINS DICLOFENAC SODIUM BP 50 MG. B4-6346 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 2/19/2021 EZECHUKS PHARMACEUTICALS COY. LIMITED., SAM EZECHUKU CLOSE OFF OSADENIS HIGH SCHOOL ROAD, ASABA. DELTA 8027817642 ezechukspharmltd@gmail.com LESANTO LABORATORIES, PLOT NO. 9, 10, 11 & 20, SURNVEY NO 53, NEAR RAILWAY BRIDGE, THANE PALGHAR 401404 MAHARASHTRA, INDIA, PLOT NO. 9, 10, 11 & 20, SURNVEY NO 53, NEAR RAILWAY BRIDGE, THANE PALGHAR 401404 MAHARASHTRA, INDIA, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB05	Diclofenac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6346